The two-day event brings together officials from the vice presidency for science and technology, the Ministry of Health, industry representatives, researchers and clinicians to discuss advances in plasma-based medical technologies.
The congress focuses on preclinical studies in plasma medicine, clinical applications, emerging technologies, biomaterials and tissue engineering, device engineering and simulation, plasma-activated environments, disinfection and sterilization, and safety, regulations and standards.
Panels scheduled over the two days address plasma applications in wound treatment, its effects on microorganisms, plasma-based cancer therapies, safety and regulatory issues, and engineering and general uses of plasma.
The event is set to conclude on Friday with the announcement of top papers and recognition of selected contributors.
Meanwhile, Mahdieh Bakhtiari, chief executive of the Plasma Technology Development Company, said the Second Iranian Plasma Medicine Congress is a “fully scientific and technological event” organized jointly by the company and Tehran University of Medical Sciences, with ongoing support from the Atomic Energy Organization of Iran and the nuclear industry.
She said the congress reflects the scientific and technological efforts of young Iranian specialists working to advance national healthcare, adding that the event aims to encourage collaboration among researchers, universities and physicians to accelerate the transfer of plasma technologies from laboratory to clinic.
Bakhtiari said the program includes specialized panels on wound care, infection control, cancer and plasma physics, along with hands-on workshops and a side exhibition showcasing the latest medical achievements.
Bakhtiari announced the unveiling of two advanced plasma-medicine systems, explaining that one device enables plasma-based drug synthesis and clinical studies, while the second represents a new generation of plasma wound-care jets designed using an AI-based algorithm.
She added that the newly established research grant targets researchers with early-stage but impactful ideas, noting that proposals will undergo detailed multidisciplinary review and the evaluation criteria will be posted on the congress website.
Bakhtiari said the initiative goes beyond financial support, adding that top recipients will also gain access to the company’s specialized biology laboratories to help advance their projects toward clinical application.